This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Champix® (varenicline tartrate) Prescribing Information.  Adverse event reporting information can be found at the bottom of the page.

Champix (varenicline) for smoking cessation in adults

CHAMPIX (varenicline tartrate), a medication which is indicated for smoking cessation in adults, is currently unavailable because of a disruption in the manufacturing of
the drug. 
While Pfizer is seeking to address the disruption as quickly as possible, at this time we are unable to confirm a date when the situation will be resolved.
We understand and regret the challenges that this situation poses to patients. Pfizer fully realizes the importance of this medicine to our customers and patients. Ensuring continuity of the supply of our medicines is paramount. Until the CHAMPIX shortage is resolved, patients will need to consult with their healthcare professional to choose an alternative treatment option.

Resources for you

Very brief advice
Patient support material

Clinical information

Champix efficacy and safety 

Find out here

PP-CHM-GBR-3764. August 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020